Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer

Eileen M. O’Reilly

Zev A. Wainberg

Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles

Andrew E. Hendifar

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles

Mitesh J. Borad

Department of Oncology, Mayo Clinic, Phoenix, AZ

Filippo Pietrantonio

Shubham Pant

M.D. Anderson Cancer Center, Houston

Pascal Hammel

Chiara Cremolini

Gulam A. Manji

Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York

Paul E. Oberstein

Department of Hematology–Oncology, NYU Langone Health, New York University, New York

Ignacio Garrido-Laguna

Huntsman Cancer Institute, University of Utah, Salt Lake City

Christoph Springfeld

Heidelberg University Hospital, National Center for Tumor Diseases, Heidelberg, Germany

Nilofer S. Azad

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore

Makoto Ueno

Stephen Y. Chui

Revolution Medicines, Redwood City, CA

Ying Zhang

Hina Patel

Revolution Medicines, Redwood City, CA

Yeonju Lee

Revolution Medicines, Redwood City, CA

Zeena Salman

Brian M. Wolpin